Literature DB >> 6205500

Enhanced neutralization of La Crosse virus by the binding of specific pairs of monoclonal antibodies to the G1 glycoprotein.

L Kingsford.   

Abstract

Monoclonal antibodies specific for eight antigenic sites on the G1 glycoprotein of La Crosse virus were studied in a kinetics of neutralization assay. When examined at the same protein concentration, there were differences in the rates and degree of neutralization induced by these antibodies. The maximum amount of neutralization detected in antibody excess ranged from 1.5 to 3 logs. Another 2 to 3 logs of viral infectivity could be neutralized by the addition of polyclonal anti-G1 antibody or a second monoclonal antibody. However, only certain pairs of monoclonal antibodies enhanced the neutralization the additional 2 to 3 logs. The antibody pairs enhancing neutralization were those also found to be synergistic in a competition binding assay (L. Kingsford, L. D. Ishizawa, and D. W. Hill, 1983, Virology 129, 443-455) as well as any neutralizing antibody used in combination with antibodies to epitopes within one particular site on the glycoprotein. The data indicate that antibody binding to two different specific sites on G1 is needed to neutralize La Crosse virus to the same extent that is observed with polyclonal antibody.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6205500     DOI: 10.1016/0042-6822(84)90163-6

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies.

Authors:  T G Besselaar; N K Blackburn
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins.

Authors:  T G Besselaar; N K Blackburn
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Selection of unique antigenic variants of Newcastle disease virus with neutralizing monoclonal antibodies and anti-immunoglobulin.

Authors:  R M Iorio; M A Bratt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

4.  A second envelope glycoprotein mediates neutralization of a pestivirus, hog cholera virus.

Authors:  E Weiland; R Ahl; R Stark; F Weiland; H J Thiel
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

Review 5.  Monoclonal antibodies: implications for virology. Brief review.

Authors:  K C McCullough
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

6.  Additive effects characterize the interaction of antibodies involved in neutralization of the primary dualtropic human immunodeficiency virus type 1 isolate 89.6.

Authors:  F Verrier; A Nádas; M K Gorny; S Zolla-Pazner
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins.

Authors:  Andrea Bertolotti-Ciarlet; Jonathan Smith; Karin Strecker; Jason Paragas; Louis A Altamura; Jeanne M McFalls; Natalia Frias-Stäheli; Adolfo García-Sastre; Connie S Schmaljohn; Robert W Doms
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

8.  Epitopes functional in neutralization of varicella-zoster virus.

Authors:  B Forghani; K W Dupuis; N J Schmidt
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

9.  Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies.

Authors:  L J Anderson; P Bingham; J C Hierholzer
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

Review 10.  The antiviral activity of antibodies in vitro and in vivo.

Authors:  P W Parren; D R Burton
Journal:  Adv Immunol       Date:  2001       Impact factor: 3.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.